NeOnc Technologies CEO Amir Heshmatpour purchased an additional 70,000 shares of the company's stock, reinforcing his confidence following positive Phase 2a results for their brain cancer treatment NEO100. This insider buying continues a pattern seen throughout 2026, highlighting optimism ahead of upcoming clinical data presentations at the Society for Neuro-Oncology meeting. NeOnc is developing treatments for aggressive brain cancers, with recent trials showing promising progression-free survival rates. Investors are watching closely as further data on NEO100 and NEO212 are expected soon, potentially impacting the company's valuation and regulatory progress.
NeOnc Technologies CEO Amir Heshmatpour's recent purchase of 70,000 shares adds to ongoing insider buying in 2026. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 09, 2026 19:41 WIB: out of 150 priced US health-sector stocks, 121 rose and 18 fell. Notable movers include NUWE at USD 4.72 (+3.06%), CTXR at USD 0.54 (-2.98%), and LQDA at USD 45.67 (+2.86%).
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
